Pharma Focus Asia

Regis Expands Laboratory Facilities for API Pharmaceutical Development and Manufacturing

Introduction:

Regis Technologies, Inc plans to expand its laboratory facilities for the development of Active Pharmaceutical Ingredients (APIs). The facility will be located in Morton Grove, Illinois.

Features:

The expanded facility covers an area of 9,000-square-foot which includes additional process chemistry and analytical laboratories, 14 additional fume hoods, a dedicated ICP-MS suite,added climate-controlled storage, various new kilo-scale reactors and process safety equipment for reaction calorimetry measurements to ensure safe control and scale-up.

This investment widens the capabilities to support the increasing custom pharma services includingvalidation, stability studies, process chemistry, solid state chemistry, analytical development and commercialisation. Moreover, the new laboratory facility also consists of an updated Variable Air Volume (VAV) air system to maintain clean energy-efficient operations.

This expansion doubles the size of the current capacity by enabling scientists in undertaking additional API projects.

It is expected that the laboratory facility will be fully operational inFebruary 2021.

Specifications:

NameRegis Technologies, Inc.
TypeExpansion
magazine-slider-image
magazine-slider-image
Cytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024